Bisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine use

dc.contributor國立臺灣師範大學健康促進與衛生教育學系zh_tw
dc.contributor.authorLee, C. Wen_US
dc.contributor.authorMuo, CH.en_US
dc.contributor.authorLiang, LA.en_US
dc.contributor.authorChang, SN.en_US
dc.contributor.authorChang, YJ.en_US
dc.contributor.authorKao, CH.en_US
dc.date.accessioned2014-12-02T06:38:30Z
dc.date.available2014-12-02T06:38:30Z
dc.date.issued2013-09-01zh_TW
dc.identifierntnulib_tp_A0615_01_007zh_TW
dc.identifier.issn0937-941Xzh_TW
dc.identifier.urihttp://rportal.lib.ntnu.edu.tw/handle/20.500.12235/40632
dc.languageen_USzh_TW
dc.publisherSpringeren_US
dc.relationOsteoporos Int, 24(9), 2519-2524.en_US
dc.relation.urihttp://dx.doi.org/10.1007/s00198-013-2331-8zh_TW
dc.titleBisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine useen_US
dc.title.alternativea population-based nested case–control studyen_US

Files

Collections